Clinical Trial Update: Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety and efficacy of lentiviral-transduced CD34+ hematopoietic stem cells in beta-thalassemia patients; sponsor Shenzhen Hem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Lentiviral-transduced CD34+ hematopoietic stem cells

Snippet

Sponsor: Shenzhen Hemogen | Conditions: Β-thalassemia | Phase 1 | Status: RECRUITING